ALK expressing desmoid fibromatosis treated with Crizotinib: a clinical case
References
- Bektas M., Bell T., Khan S., Tumminello B., Fernandez M.M., Heyes C., et al. Desmoid Tumors: A Comprehensive Review. Adv Ther. 2023;40(9):3697–3722. doi: 10.1007/s12325-023-02592-0.
- Mikhael R., Smith M., Tzanis D., Watson S., Miah A.B., Bonvalot S. Desmoid tumors: who, when and how to treat? Curr Opin Oncol. 2022;34(4): 335–341. doi: 10.1097/CCO.0000000000000854.
- Palacios-Fuenmayor L.J., Naranjo-Isaza A.M., Fuentes O., Palacio M.F., Martelo A., Gómez L.R., et al. Intraabdominal desmoid tumor. Clinical clinical case and literature review. Cir. 2020;88(3):361–365. doi: 10.24875/CIRU.19001011.
- Yadrina A.V., Bukharov A.V., Derzhavin V.A., Golubev P.V. Surgical treatment options for extra-abdominal desmoid fibromas. Science and Innovation - Modern Concepts: a collection of scientific articles based on the results of the International Scientific Forum. Ufa: Infiniti; 2019. 2: 66–78. (In Russian).
- Desurmont T., Lefevre J.H., Shields C., Colas C., Tiret E., Parc Y. Desmoid tumour in familial adenomatous polyposis patients: responses to treatments. Fam Cancer. 2015;14(1): 31–9.
- Riedel R.F., Agulnik M. Evolving strategies for management of desmoid tumor. Cancer. 2022;128(16):3027–3040. doi: 10.1002/cncr.34332.
- Kasper B., Baldini E.H., Bonvalot S., Callegaro D., Cardona K., Colombo C., et al. Current Management of Desmoid Tumors: A Review. JAMA Oncol. 2024;10(8): 1121–1128. doi: 10.1001/jamaoncol.2024.1805.
- Chissov V.I., Darialova S.L., Boyko A.V., Koroleva L.A. Treatment of desmoid fibromas in the P.A. Herzen Moscow Research Oncology Institute (evolution of principled approaches during 30 years). 1997. 3: 13–17.
- Wu J, Hu Y, Abdihamid O, Huang G, Xiao S, Li B. Crizotinib in Sarcomatous Malignancies Harboring ALK Fusion With a Definitive Partner(s): Response and Efficacy. Front Oncol. 2021;11:684865.
- Cook J.R., Dehner L.P., Collins M.H., Zhigui M., Stephan W.M., Coffin C.M., et al. Anaplastic Lymphoma Kinase (ALK) Expression in the Inflammatory Myofibroblastic Tumor: A Comparative Immunohistochemical Study. The American Journal of Surgical Pathology. 2001;25(11):1364–1371. doi: 10.3389/fonc.2021.684865
- Jafri S.F., Obaisi O., Vergara G.G., Cates J., Singh J., Feeback J., et al. Desmoid type fibromatosis: A case report with an unusual etiology. World J Gastrointest Oncol. 2017;9(9):385–389.
- Bertucci F., Faure M., Ghigna M.R., Chetaille B., Guiramand J., Moureau-Zabotto L., et al. High-grade soft tissue sarcoma arising in a desmoid tumor: case report and review of the literature. Clin Sarcoma Res. 2015; 5:25. doi: 10.1186/s13569-015-0040-0. PMID: 26629326; PMCID: PMC4665918.
- Soule E.H., Scanlon P.W. Fibrosarcoma arising in an extraabdominal desmoid tumor: report of case. Proc Staff Meet Mayo Clin. 1962;37:443–451
- O’Connor M.I., Kransdorf M.J., Menke D.M. Soft-tissue malignant fibrous histiocytoma (high-grade undifferentiated pleomorphic sarcoma) arising in a desmoid tumor in a patient with Milroy’s disease. Skeletal Radiol. 2006; 35:240–243. doi: 10.1007/s00256-005-0007-y.
- Cates J.M., Black J, Wolfe C.C., Shinohara E.T., Holt G.E., Keedy V.L. et al. Morphologic and immunophenotypic analysis of desmoid-type fibromatosis after radiation therapy. Hum Pathol. 2012;43:1418–1424. doi: 10.1016/j.humpath.2011.11.002.
- Nascimento A.F., Raut C.P. Diagnosis and management of pleomorphic sarcomas (so-called “MFH”) in adults. J Surg Oncol. 2008;97:330–339. doi: 10.1002/jso.20972.
- Hardy J.D. The ubiquitous fibroblast. Multiple oncogenic potentials with illustrative cases. Ann Surg. 1987;205:445–455. doi: 10.1097/00000658-198705000-00002.
- Shreenivas A., Janku F., Gouda M.A., Chen H.Z., George B., Kato S. et al. ALK fusions in the pan-cancer setting: another tumor-agnostic target? npj Precis. Onc. 2023;7:101. doi: 10.1038/s41698-023-00449-x.
- Takeyasu Y., Okuma H.S., Kojima Y., Nishikawa T., Tanioka M., Sudo K. et. al. Impact of ALK Inhibitors in Patients With ALK-Rearranged Nonlung Solid Tumors. JCO Precis Oncol. 2021;5:PO.20.00383. doi: 10.1200/PO.20.00383.
Language: English
Submitted on: Jun 3, 2025
Accepted on: Sep 1, 2025
Published on: Jul 14, 2026
Published by: Helenic Society of Medical Oncology
In partnership with: Paradigm Publishing Services
Keywords:
Related subjects:
© 2026 Polina Eduardovna Kopylova, Rajesh Ranjit, Anna Viktorovna Yadrina, Vitaly Andreevich Derzhavin, Artem Viktorovich Bukharov, Mamed Javadovich Aliev, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.